Expression of plasminogen activator inhibitor-1 and protease nexin-1 in human astrocytes: Response to injury-related factors

Journal of Neuroscience Research

Volumn 88, Issue 11, 2010, Pages 2441-2449

  Hultman, Karin ^a,b   Blomstrand, Fredrik ^a,b   Nilsson, Michael ^a   Wilhelmsson, Ulrika ^a   Malmgren, Kristina ^a   Pekny, Milos ^a   Kousted, Tina ^c   Jern, Christina ^a,b   Tjärnlund Wolf, Anna ^a,b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

Astroglia; Cytokines; Gene expression; Hypoxia

Indexed keywords

CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEASE NEXIN I; SERINE PROTEINASE INHIBITOR; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; AMYLOID PRECURSOR PROTEIN; CELL SURFACE RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; PROTEASE NEXIN; SERPINE2 PROTEIN, HUMAN;

ARTICLE; ASTROCYTE; BRAIN TISSUE; CELL HYPOXIA; CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR ACCIDENT; CONTRAST; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE CONTROL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NERVE CELL LESION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TEMPORAL CORTEX; BIOSYNTHESIS; BRAIN HYPOXIA; BRAIN INJURY; BRAIN LEVEL; CELL CULTURE; GENE EXPRESSION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY;

AMYLOID BETA-PROTEIN PRECURSOR; ASTROCYTES; BRAIN CHEMISTRY; BRAIN INJURIES; CELL HYPOXIA; CELLS, CULTURED; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; HYPOXIA, BRAIN; IMMUNOHISTOCHEMISTRY; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEASE NEXINS; RECEPTORS, CELL SURFACE; RNA, MESSENGER; SERPIN E2; SERPINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77955354679     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22412     Document Type: Article

References (42)

1. Ali C, Docagne F, Nicole O, Lesne S, Toutain J, Young A, Chazalviel L, Divoux D, Caly M, Cabal P, Derlon JM, MacKenzie ET, Buisson A, Vivien D. 2001. Increased expression of transforming growth factorbeta after cerebral ischemia in the baboon: an endogenous marker of neuronal stress? J Cereb Blood Flow Metab 21:820-827.
2. Cacquevel M, Launay S, Castel H, Benchenane K, Cheenne S, Buee L, Moons L, Delacourte A, Carmeliet P, Vivien D. 2007. Ageing and amyloidbeta peptide deposition contribute to an impaired brain tissue plasminogen activator activity by different mechanisms. Neurobiol Dis 27:164-173. (Pubitemid 47096796)
3. Calabresi P, Napolitano M, Centonze D, Marfia GA, Gubellini P, Teule MA, Berretta N, Bernardi G, Frati L, Tolu M, Gulino A. 2000. Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory. Eur J Neurosci 12:1002-1012. (Pubitemid 30168779)
4. Chmielewska J, Ranby M, Wiman B. 1988. Kinetics of the inhibition of plasminogen activators by the plasminogen-activator inhibitor. Evidence for "second-site" interactions. Biochem J 251:327-332.
5. Choi BH, Suzuki M, Kim T, Wagner SL, Cunningham DD. 1990. Protease nexin-1. Localization in the human brain suggests a protective role against extravasated serine proteases. Am J Pathol 137:741-747.
6. de Castro Ribeiro M, Badaut J, Price M, Meins M, Bogousslavsky J, Monard D, Hirt L. 2006. Thrombin in ischemic neuronal death. Exp Neurol 198:199-203.
7. Dietzmann K, von Bossanyi P, Krause D, Wittig H, Mawrin C, Kirches E. 2000. Expression of the plasminogen activator system and the inhibitors PAI-1 and PAI-2 in posttraumatic lesions of the CNS and brain injuries following dramatic circulatory arrests: an immunohistochemical study. Pathol Res Pract 196:15-21. (Pubitemid 30046522)
8. Dimova EY, Kietzmann T. 2008. Metabolic, hormonal and environmental regulation of plasminogen activator inhibitor-1 (PAI-1) expression: lessons from the liver. Thromb Haemost 100:992-1006.
9. Docagne F, Nicole O, Marti HH, MacKenzie ET, Buisson A, Vivien D. 1999. Transforming growth factor-beta1 as a regulator of the serpins/t-PA axis in cerebral ischemia. FASEB J 13:1315-1324.
10. Donovan FM, Pike CJ, Cotman CW, Cunningham DD. 1997. Thrombin induces apoptosis in cultured neurons and astrocytes via a pathway requiring tyrosine kinase and RhoA activities. J Neurosci 17:5316-5326.
11. Fabbro S, Seeds NW. 2009. Plasminogen activator activity is inhibited while neuroserpin is up-regulated in the Alzheimer disease brain. J Neurochem 109:303-315.
12. Fink T, Kazlauskas A, Poellinger L, Ebbesen P, Zachar V. 2002. Identification of a tightly regulated hypoxia-response element in the promoter of human plasminogen activator inhibitor-1. Blood 99:2077-2083.
13. Gabriel C, Ali C, Lesne S, Fernandez-Monreal M, Docagne F, Plawinski L, MacKenzie ET, Buisson A, Vivien D. 2003. Transforming growth factor alpha-induced expression of type 1 plasminogen activator inhibitor in astrocytes rescues neurons from excitotoxicity. FASEB J 17:277-279.
14. Gravanis I, Tsirka SE. 2005. Tissue plasminogen activator and glial function. Glia 49:177-183. (Pubitemid 40188497)
15. Gveric D, Hanemaaijer R, Newcombe J, van Lent NA, Sier CF, Cuzner ML. 2001. Plasminogen activators in multiple sclerosis lesions: implications for the inflammatory response and axonal damage. Brain 124:1978-1988.
16. Hastings GA, Coleman TA, Haudenschild CC, Stefansson S, Smith EP, Barthlow R, Cherry S, Sandkvist M, Lawrence DA. 1997. Neuroserpin, a brain-associated inhibitor of tissue plasminogen activator is localized primarily in neurons. Implications for the regulation of motor learning and neuronal survival. J Biol Chem 272:33062-33067.
17. Hultman K, Tjarnlund-Wolf A, Fish RJ, Wilhelmsson U, Rydenhag B, Pekny M, Kruithof EK, Jern C. 2008. Retinoids and activation of PKC induce tissue-type plasminogen activator expression and storage in human astrocytes. J Thromb Haemost 6:1796-1803.
18. Justicia C, Perez-Asensio FJ, Burguete MC, Salom JB, Planas AM. 2001. Administration of transforming growth factor-alpha reduces infarct volume after transient focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 21:1097-1104. (Pubitemid 32823745)
19. Kasza A, Kiss DL, Gopalan S, Xu W, Rydel RE, Koj A, Kordula T. 2002. Mechanism of plasminogen activator inhibitor-1 regulation by oncostatin M and interleukin-1 in human astrocytes. J Neurochem 83:696-703.
20. Kruithof EK. 2008. Regulation of plasminogen activator inhibitor type 1 gene expression by inflammatory mediators and statins. Thromb Haemost 100:969-975.
21. Krupinski J, Kumar P, Kumar S, Kaluza J. 1996. Increased expression of TGF-beta 1 in brain tissue after ischemic stroke in humans. Stroke 27:852-857. (Pubitemid 26142515)
22. Nagamine Y. 2008. Transcriptional regulation of the plasminogen activator inhibitor type 1 - with an emphasis on negative regulation. Thromb Haemost 100:1007-1013.
23. Ohyama H, Hosomi N, Takahashi T, Mizushige K, Kohno M. 2001. Thrombin inhibition attenuates neurodegeneration and cerebral edema formation following transient forebrain ischemia. Brain Res 902:264-271.
24. Planas AM, Gorina R, Chamorro A. 2006. Signalling pathways mediating inflammatory responses in brain ischaemia. Biochem Soc Trans 34:1267-1270. (Pubitemid 46769035)
25. Prehn JH, Backhauss C, Krieglstein J. 1993. Transforming growth factorbeta 1 prevents glutamate neurotoxicity in rat neocortical cultures and protects mouse neocortex from ischemic injury in vivo. J Cereb Blood Flow Metab 13:521-525.
26. Qian Z, Gilbert ME, Colicos MA, Kandel ER, Kuhl D. 1993. Tissueplasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation. Nature 361:453-457.
27. Schacke W, Beck KF, Pfeilschifter J, Koch F, Hattenbach LO. 2002. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells. Invest Ophthalmol Vis Sci 43:2799-2805. (Pubitemid 34809475)
28. Scott RW, Bergman BL, Bajpai A, Hersh RT, Rodriguez H, Jones BN, Barreda C, Watts S, Baker JB. 1985. Protease nexin. Properties and a modified purification procedure. J Biol Chem 260:7029-7034.
29. Stoll G, Jander S, Schroeter M. 1998. Inflammation and glial responses in ischemic brain lesions. Prog Neurobiol 56:149-171.
30. Strle K, Zhou JH, Shen WH, Broussard SR, Johnson RW, Freund GG, Dantzer R, Kelley KW. 2001. Interleukin-10 in the brain. Crit Rev Immunol 21:427-449.
31. Takano T, Oberheim N, Cotrina ML, Nedergaard M. 2009. Astrocytes and ischemic injury. Stroke 40:8-12.
32. Teesalu T, Kulla A, Simisker A, Siren V, Lawrence DA, Asser T, Vaheri A. 2004. Tissue plasminogen activator and neuroserpin are widely expressed in the human central nervous system. Thromb Haemost 92:358-368.
33. Tsirka SE, Rogove AD, Bugge TH, Degen JL, Strickland S. 1997. An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J Neurosci 17:543-552. (Pubitemid 27024567)
34. Tuttolomondo A, Di Raimondo D, di Sciacca R, Pinto A, Licata G. 2008. Inflammatory cytokines in acute ischemic stroke. Curr Pharm Des 14:3574-3589.
35. Ulfhammer E, Ridderstrale W, Andersson M, Karlsson L, Hrafnkelsdottir T, Jern S. 2005. Prolonged cyclic strain impairs the fibrinolytic system in cultured vascular endothelial cells. J Hypertens 23:1551-1557.
36. Vaughan PJ, Cunningham DD. 1993. Regulation of protease nexin-1 synthesis and secretion in cultured brain cells by injury-related factors. J Biol Chem 268:3720-3727.
37. Wolf AT, Medcalf RL, Jern C. 2005. The t-PA -7351C→T enhancer polymorphism decreases Sp1 and Sp3 protein binding affinity and transcriptional responsiveness to retinoic acid. Blood 105:1060-1067.
38. Wu H, Zhao R, Qi J, Cong Y, Wang D, Liu T, Gu Y, Ban X, Huang Q. 2008. The expression and the role of protease nexin-1 on brain edema after intracerebral hemorrhage. J Neurol Sci 270:172-183.
39. Yepes M, Sandkvist M, Wong MK, Coleman TA, Smith E, Cohan SL, Lawrence DA. 2000. Neuroserpin reduces cerebral infarct volume and protects neurons from ischemia-induced apoptosis. Blood 96:569-576. (Pubitemid 30463377)
40. Yepes M, Sandkvist M, Moore EG, Bugge TH, Strickland DK, Lawrence DA. 2003. Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J Clin Invest 112:1533-1540.
41. Yepes M, Roussel BD, Ali C, Vivien D. 2009. Tissue-type plasminogen activator in the ischemic brain: more than a thrombolytic. Trends Neurosci 32:48-55.
42. Yoshida H, Imaizumi T, Tanji K, Sakaki H, Metoki N, Sato Y, Wakabayashi K, Kimura H, Satoh K. 2006. Interleukin-1beta enhances the angiotensin-induced expression of plasminogen activator inhibitor-1 through angiotensin receptor upregulation in human astrocytes. Brain Res 1073/1074:38-47.